Towards image-guided photodynamic therapy of glioblastoma

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 8568, Issue , 2013, Pages

  Mallidi, Srivalleesha ^a   Huang, Huang Chiao ^a   Liu, Joyce ^a   Mai, Zhiming ^a   Hasan, Tayyaba ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Dosimetry; Glioblastoma; Photoacoustic imaging; Photodynamic therapy; Photosensitizer

Indexed keywords

3D INFORMATION; DOSE PARAMETERS; FLUORESCENCE GUIDED RESECTION; GLIOBLASTOMAS; OPTICAL ABSORPTION PROPERTIES; PHOTO-ACOUSTIC IMAGING; PHOTODYNAMIC THERAPY (PDT); THERAPEUTIC MODALITY;

DISEASES; DOSIMETRY; FLUORESCENCE; PHOTOACOUSTIC EFFECT; PHOTOSENSITIZERS; TUMORS;

PHOTODYNAMIC THERAPY;

EID: 84878119955     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.2010684     Document Type: Conference Paper

References (47)

1. Minniti, G., Muni, R., Lanzetta, G., Marchetti, P., and Enrici, R.M., Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents., Anticancer research 29(12), 5171-5184 (2009).
2. Welsh, C.T., Molecular Mechanisms of Pathogenesisin Glioblastoma and Current Therapeutic Strategies, Glioblastoma, 85-93 (2010).
3. Nieder, C., Grosu, A.L., and Molls, M., A comparison of treatment results for recurrent malignant gliomas, Cancer Treatment Reviews 26(6), 397-409 (2000).
4. Schnell, O., and Tonn, J.C., Unmet Medical Needs in Glioblastoma Management and Optimal Sequencing of the Emerging Treatment Options, European journal of Clinical and Medical Oncology 2(1), 41-49 (2010).
5. McNamara, M.G., and Mason, W.P., Antiangiogenic therapies in glioblastoma multiforme, Expert Review of Anticancer Therapy 12(5), 643-654 (2012).
6. Cimini, A., and Ippoliti, R., Innovative Therapies against Human Glioblastoma Multiforme., ISRN oncology 2011, 787490 (2011).
7. Clarke, J., Butowski, N., and Chang, S., Recent advances in therapy for glioblastoma., Archives of neurology 67(3), 279-283 (2010).
8. Bouffet, E., Tabori, U., Huang, A., and Bartels, U., Possibilities of new therapeutic strategies in brain tumors, Cancer Treatment Reviews 36(4), 335-341 (2010).
9. Quant, E.C., and Wen, P.Y., Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials., Neuroimaging clinics of North America 20(3), 425-448 (2010).
10. Moustakas, A., and Kreisl, T.N., New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab, OncoTargets and therapy 3, 27 (2010).
11. Li, J., Di, C., Mattox, A.K., Wu, L., and Adamson, D.C., The future role of personalized medicine in the treatment of glioblastoma multiforme., Pharmacogenomics and personalized medicine 3, 111-127 (2010).
12. Nieder, C., Adam, M., and Grosu, A.L., Combined modality treatment of glioblastoma multiforme: the role of temozolomide., Reviews on Recent Clinical Trials 1(1), 43-51 (2006).
13. Noske, D.P., Wolbers, J.G., and Sterenborg, H.J., Photodynamic therapy of malignant glioma. A review of literature., Clinical Neurology and Neurosurgery 93(4), 293-307 (1991).
14. Ritz, R., Visualization and Photodynamic Therapy in Malignant Glioma-An Overview and Perspectives, Advances in the Biology, Imaging and Therapies for Glioblastoma(10), 183-198 (2011).
15. Kostron, H., Photodynamic diagnosis and therapy and the brain., Methods in molecular biology (Clifton, N.J.) 635, 261-280 (2010).
16. Eljamel, S., Photodynamic applications in brain tumors: A comprehensive review of the literature, Photodiagnosis and Photodynamic Therapy 7(2), 76-85 (2010).
17. Stylli, S.S., and Kaye, A.H., Photodynamic therapy of cerebral glioma-A review Part II-Clinical studies, Journal of Clinical Neuroscience 13(7), 709-717 (2006).
18. Stylli, S.S., Kaye, A.H., MacGregor, L., Howes, M., and Rajendra, P., Photodynamic therapy of high grade glioma-long term survival, Journal of Clinical Neuroscience 12(4), 389-398 (2005).
19. Shinoda, J., Yano, H., Yoshimura, S.-I., Okumura, A., Kaku, Y., Iwama, T., and Sakai, N., Fluorescenceguided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note., Journal of neurosurgery 99(3), 597-603 (2003).
20. Stummer, W., Novotny, A., Stepp, H., Goetz, C., Bise, K., and Reulen, H.J., Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients, Journal of neurosurgery 93(6), 1003-1013 (2000).
21. Valdés, P.A., Kim, A., Brantsch, M., Niu, C., Moses, Z.B., Tosteson, T.D., Wilson, B.C., Paulsen, K.D., Roberts, D.W., et al., δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy., Neuro-Oncology 13(8), 846-856 (2011).
22. Celli, J.P., Spring, B.Q., Rizvi, I., Evans, C.L., Samkoe, K.S., Verma, S., Pogue, B.W., and Hasan, T., Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization, Chemical Reviews 110(5), 2795-2838 (2010).
23. Pogue, B.W., Samkoe, K.S., Gibbs-Strauss, S.L., and Davis, S.C., Fluorescent molecular imaging and dosimetry tools in photodynamic therapy., Methods in molecular biology (Clifton, N.J.) 635, 207-222 (2010).
24. Wilson, B.C., Patterson, M.S., and Lilge, L., Implicit and explicit dosimetry in photodynamic therapy: a New paradigm., Lasers in Medical Science 12(3), 182-199 (1997).
25. Zhou, X., Pogue, B.W., Chen, B., Demidenko, E., Joshi, R., Hoopes, J., and Hasan, T., Pretreatment photosensitizer dosimetry reduces variation in tumor response, International Journal of Radiation Oncology Biology Physics 64(4), 1211-1220 (2006).
26. Bayer, C.L., Luke, G.P., and Emelianov, S.Y., Photoacoustic Imaging for Medical Diagnostics, Acoustics Today 8(4), 15-23 (2012).
27. Emelianov, S.Y., Li, P.C., and O'Donnell, M., Photoacoustics for molecular imaging and therapy, Physics today 62(8), 34 (2009).
28. Kim, C., Favazza, C., and Wang, L.V., In Vivo Photoacoustic Tomography of Chemicals: High-Resolution Functional and Molecular Optical Imaging at New Depths, Chemical Reviews 110(5), 2756-2782 (2010).
29. Li, C., and Wang, L.V., Photoacoustic tomography and sensing in biomedicine, Physics in Medicine and Biology 54(19), R59-R97 (2009).
30. Luke, G.P., Yeager, D., and Emelianov, S.Y., Biomedical Applications of Photoacoustic Imaging with Exogenous Contrast Agents, Annals of Biomedical Engineering 40(2), 422-437 (2011).
31. Mallidi, S., Luke, G.P., and Emelianov, S.Y., Photoacoustic imaging in cancer detection, diagnosis, and treatment guidance., Trends in Biotechnology 29(5), 213-221 (2011).
32. Ntziachristos, V., and Razansky, D., Molecular Imaging by Means of Multispectral Optoacoustic Tomography (MSOT), Chemical Reviews 110(5), 2783-2794 (2010).
33. Valluru, K., Chinni, B., and Rao, N., Photoacoustic Imaging: Opening New Frontiers in Medical Imaging, Journal of Clinical Imaging Science 1(1), 24 (2011).
34. Wang, L.V., Prospects of photoacoustic tomography, Medical Physics 35(12), 5758 (2008).
35. Moreira, L., Juliana, L., Ana, R.P., Divinomarr, S., Regina, M., and de Oliveira, H.P.M., Phenotiazinium Dyes as Photosensitizers (PS) in Photodynamic Therapy (PDT): Spectroscopic Properties and Photochemical Mechanisms, Advanced Aspects of Spectroscopy, 393-422 (2012).
36. Ashkenazi, S., Photoacoustic lifetime imaging of dissolved oxygen using methylene blue, Journal of Biomedical Optics 15(4), 040501 (2010).
37. Kim, C., Erpelding, T.N., Jankovic, L., Pashley, M.D., and Wang, L.V., Deeply penetrating in vivo photoacoustic imaging using a clinical ultrasound array system., Biomedical optics express 1(1), 278-284 (2010).
38. Hirao, A., Sato, S., Saitoh, D., Shinomiya, N., Ashida, H., and Obara, M., In VivoPhotoacoustic Monitoring of Photosensitizer Distribution in Burned Skin for Antibacterial Photodynamic Therapy, Photochemistry and Photobiology 86(2), 426-430 (2010).
39. Hamblin, M.R., and Hasan, T., Photodynamic therapy: a new antimicrobial approach to infectious disease?, Photochemical & Photobiological Sciences 3(5), 436-450 (2004).
40. Tang, W., Xu, H., Kopelman, R., and Philbert, M.A., Photodynamic characterization and in vitro application of methylene blue-containing nanoparticle platforms., Photochemistry and Photobiology 81(2), 242-249 (2005).
41. Hah, H.J., Kim, G., Lee, Y.-E.K., Orringer, D.A., Sagher, O., Philbert, M.A., and Kopelman, R., Methylene Blue-Conjugated Hydrogel Nanoparticles and Tumor-Cell Targeted Photodynamic Therapy, Macromolecular Bioscience 11(1), 90-99 (2010).
42. Orth, K., Beck, G., Genze, F., and Rück, A., Methylene blue mediated photodynamic therapy in experimental colorectal tumors in mice, Journal of Photochemistry & Photobiology, B: Biology 57(2), 186-192 (2000).
43. He, X., Wu, X., Wang, K., Shi, B., and Hai, L., Methylene blue-encapsulated phosphonate-terminated silica nanoparticles for simultaneous in vivo imaging and photodynamic therapy, Biomaterials 30(29), 5601-5609 (2009).
44. Bristol, D.W., Technical Report on Toxicology and Carcinogenesis Studies of Methylene Blue Trihydrate (CAS No. 7220-79-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies), NIH Publication No. 08-4429 (2008).
45. Jesorka, A., and Orwar, O., Liposomes: Technologies and Analytical Applications, Annual Review of Analytical Chemistry 1(1), 801-832 (2008).
46. Xiang, L., Xing, D., Gu, H., Yang, D., Yang, S., Zeng, L., and Chen, W.R., Real-time optoacoustic monitoring of vascular damage during photodynamic therapy treatment of tumor, Journal of Biomedical Optics 12(1), 014001 (2007).
47. Rai, P., Mallidi, S., Zheng, X., Rahmanzadeh, R., Mir, Y., Elrington, S., Khurshid, A., and Hasan, T., Development and applications of photo-triggered theranostic agents, Advanced Drug Delivery Reviews 62(11), 1094-1124 (2010).